How targeting killer T cells in the lungs could lead to immunity against respiratory viruses

LA JOLLA—A significant site of damage during COVID-19 infection is the lungs. Understanding how the lungs’ immune cells are responding to viral infections could help scientists develop a vaccine.

The post How targeting killer T cells in the lungs could lead to immunity against respiratory viruses appeared first on Salk Institute for Biological Studies.